Canada

Search form

MyoSure Hysteroscopic Tissue Removal System

Simply Efficient.

The Myosure system provides a simple and accurate solution for intrauterine tissue removal including fibroids and polyps.
If your doctor has told you that fibroids or polyps are likely causing your painful periods, take heart. You can take action with the Myosure procedure. 

About

As part of our dedication to women's health, Hologic offers the MyoSure hysteroscopic tissue removal system. This procedure is an innovative treatment that enables incision-less, fast removal of intrauterine pathology. The MyoSure system pairs direct hysteroscopic visualization with minimally invasive tissue resection that requires no cauterization, ultimately preserving uterine form and function, including tissue margins. The procedure resects the pathology while simultaneously extracting resected tissue from the uterine cavity using suction. You can perform every stage of assessment and removal with a single MyoSure scope, which offers the easiest way to see the anatomy and guide the procedure.

The MyoSure system is an ideal treatment option for women of all ages, including women wishing to preserve their childbearing ability.  The MyoSure system offers your practice these key benefits: 

  • Minimizes disruption to procedural workflow.
  • Provides one versatile tool that enables you to both diagnose and treat patients.
  • Maximizes staff efficiency.
Prevalence, Characteristics and Causes

AUB (abnormal uterine bleeding) is more common than most women think. It’s estimated that AUB affects 1 out of every 5 women — that’s about 10 million women!1

The most common causes of AUB are intrauterine pathology, including polyps and fibroids.

Polyps:

Endometrial polyps are small, protrusions of tissue that grow on the uterine lining (endometrium). The prevalence is reported to be between 7.8% to 34.9%, depending on the population being studied.2

Fibroids:

Fibroids are non-cancerous tissue growths in the muscle walls of the uterus. In the United States, the prevalence of polyps is women ages 33-40 is 40% for caucasian patients and 60% for African American patients.3

In addition to causing AUB, polyps and fibroids may also challenge a woman's reproductive health.4

Our Technology

Our MyoSure system technology offers condition-specific options for removing intrauterine pathology.

MyoSure LITE — designed to remove a 3 cm polyp in less than 2 minutes:

  • 3 mm stainless steel blade.
  • Compatible with MyoSure 6 mm and MyoSure XL 7 mm hysteroscopes.
  • 7.0 grams/min tissue removal (polyp tissue).

 

MyoSure  — designed to remove a 3 cm fibroid in less than 10 minutes:

  • 3 mm coated stainless steel blade with high wear resistance.
  • Compatible with MyoSure 6 mm and MyoSure XL 7 mm hysteroscopes.
  • 1.5 grams/min tissue removal (fibroid tissue).

 

MyoSure XL— designed to remove a 5 cm fibroid in less than 15 minutes:

  • All the features of the MyoSure device with a more robust design for large fibroids or when maximum cutting efficiency is required.
  • 4 mm coated stainless steel blade with high wear resistance.
  • Compatible with MyoSure XL 7 mm hysteroscope. 
  • 4.3 grams/min removal of fibroid tissue.
Features

Unique features of the MyoSure system include: 

Direct visualization and assessment of uterine cavity

  • Rod lens technology provides a clear, bright image with enhanced resolution and superior color contrast.

Treatment of pathology 

  • The MyoSure tissue removal device is inserted through the positioned MyoSure scope to simultaneously cut and remove tissue. It offers:

     - 0° direction of view and 80° field of view, with direct visualization of tissue removal and a panoramic view of the uterine cavity.

     - Small 6 mm outer diameter that minimizes cervical dilation.

     - Continuous flow with removable outflow channel.

     - Unique seal technology, which prevents fluid splash-back and is compatible with 5-9 Fr. instruments

Important Safety Information

Important Safety Information:

The MyoSure Hysteroscopic Tissue Removal System is intended for hysteroscopic intrauterine procedures by trained gynecologists to resect and remove tissue including
submucous myomas and endometrial polyps. It is not appropriate for patients who are or may be pregnant, or are exhibiting pelvic infection, cervical malignancies or previously diagnosed endometrial cancer.

For more information please review the instructions for use.

References

1. National Women’s Health Resource Center. Survey of women who experience heavy menstrual bleeding. Data on file; 2005.

2. J Minim Invasive Gynecol. 2012 Jan-Feb;19(1):3-10. doi: 10.1016/j.jmig.2011.09.003.

 

3. J Minim Invasive Gynecol. 2012 Mar-Apr;19(2):152-71. doi: 10.1016/j.jmig.2011.09.005.

4. Pritts E, et al. Fibroids and Infertility: an updated systematic review of the evidence, Fertility and Sterility, 2009 April;91(4):1215-1223.